KRDXF yields 2.27% · PFE yields 6.13%● Live data
📍 KRDXF pulled ahead of the other in Year 1
Combined, KRDXF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KRDXF + PFE for your $10,000?
Kardex Holding AG provides intralogistics solutions; and supplies automated storage solutions and materials handling systems worldwide. The company operates in two segments, Kardex Remstar and Kardex Mlog. The Kardex Remstar segment develops, produces, and maintains dynamic storage and retrieval systems. The Kardex Mlog segment offers integrated material handling systems and automated high bay warehouses. The company provides vertical buffer, carousel, and lift, as well as horizontal carousel modules; heavy duty units; office solutions; stacker cranes; AutoStore; pick and place robotics; conveyor systems; software and control solutions; and accessories. Its products are used in automated storage and retrieval systems, buffering and sequencing, order fulfillment, controlled environment, document storage, and general contractor applications. Kardex Holding AG is headquartered in Zurich, Switzerland.
Full KRDXF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.